Ulf Bömer

This inventor holds 70 USPTO granted patents and 36 published patent applications, plus 2 CIPO patents and 54 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh, Bayer Aktiengesellschaft. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulf Bömer. Retrieved from https://idiyas.com/inventor/ulf-bomer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 70 (Patent Applications = 36)

% Patents Active = 35.7

CIPO Patents = 2 (Patent Applications = 14)

EPO Patents = 54 (Patent Applications = 84)

Average Co-Inventor Count = 8.7

ph-index = 8

Forward Citations = 231(Granted Patents)

Forward Citations (Not Self Cited) = 181(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Glienicke/Nordbahn, DE (2013)
Berlin, DE (2017 - 2019)
Glienicke, DE (2011 - 2024)

Company Filing History:

33 out of 387

Bayer Pharma Aktiengesellschaft

patents

32 out of 721

Bayer Intellectual Property Gmbh

patents

5 out of 12,270

Bayer Aktiengesellschaft

patents

4. 4 out of 490

The Broad Institute, Inc.

patents

5. 3 out of 1,273

Dana-Farber-Cancer Institute Inc.

patents

6. 2 out of 159

Deutsches Krebsforschungszentrum

patents

7. 1 out of 55

Bayer Animal Health Gmbh

patents

8. 1 out of 192

Bayer Schering Pharma Ag

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Indazoles

Pyridazines

Kinase Inhibitors

Aminoquinolones

Triazolopyridines

Sulfoximine Compounds

Heteroaromatic Compounds

Macrocyclic Compounds

Carboxamides

Pyrimidine Derivatives

Pyrrolotriazines

Aminoimidazopyridazines

70 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692261 - Substituted heterocyclic compounds and therapeutic uses thereof (2026-07-28),

2. 12679836 - 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS (2026-07-14),

3. 12565496 - SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF (2026-03-03),

4. 12559473 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs (2026-02-24),

5. 12478621 - SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION (2025-11-25),

6. 12227501 - 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors (2025-02-18),

7. 12006304 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs (2024-06-11),

8. 12006303 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs (2024-06-11),

9. 11998539 - Substituted aminoquinolones as DGKalpha inhibitors for immune activation (2024-06-04),

10. 11339157 - 4H-pyrrolo[3,2-c]pyridin-4-one derivatives (2022-05-24),

11. 11077111 - Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals (2021-08-03),

12. 10894784 - Heteroarylbenzimidazole compounds (2021-01-19),

13. 10793545 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs (2020-10-06),

14. 10729680 - 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines (2020-08-04),

15. 10435396 - 2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs (2019-10-08),

Title: Ulf Bömer: Pioneering Sustainable Innovations for a Better Tomorrow

Introduction: Ulf Bömer, a visionary inventor hailing from Glienicke, DE, is a true pioneer in the world of innovation. With an impressive portfolio of 62 patents, his relentless pursuit of creating a more sustainable future through technology has solidified his position as a trailblazer in the industry.

Latest Patents: Among his latest patents is the groundbreaking work on substituted indazoles. These novel compounds have shown promise in the treatment and prophylaxis of various diseases such as endometriosis, lymphoma, rheumatoid arthritis, and many more. Ulf Bömer's innovative approach to pharmaceutical preparations paves the way for advancements in medical research and patient care.

Career Highlights: Ulf Bömer has made significant contributions to the field through his work with renowned companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His expertise and dedication have led to the development of cutting-edge technologies that address important medical needs and improve quality of life for patients worldwide.

Collaborations: Throughout his career, Ulf Bömer has collaborated with top professionals in the industry, including Philip Lienau and Arne Scholz. These collaborations have been instrumental in expanding the scope of his inventions and driving innovation forward.

Conclusion: Ulf Bömer's passion for innovation and his commitment to creating a sustainable future through technology make him a standout figure in the world of inventors. His contributions not only inspire the current generation but also shape the landscape of innovation for generations to come. Ulf Bömer's work serves as a testament to the power of ingenuity and its potential to transform the world for the better.

Profile summary based on public USPTO records.